Fundraising Fox
Osseus
YC S26Founded 2026 · 2 employees · 2 known investors
Find your way into Osseus
Sign up to see every warm intro you have to Osseus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Osseus team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Osseus builds a permissioned research brain that connects tools and data across R&D teams to surface past experiments, expert knowledge, and next actions. The platform serves technical and research teams in biotech, manufacturing, and similar knowledge-intensive industries by maintaining continuous memory of how work evolved and preventing repeated efforts.
AI & Machine LearningBiotechData & InfrastructureDeveloper ToolsEnterprise SoftwareFuture of WorkRoboticsB2BHealthcareData EngineeringAI
Founders & leadership· Y Combinator alumni (S26)
Osseus was founded in 2026 by Anish Mariathasan and Ayush Patel.
AM
Anish MariathasanCo-FounderAnish Mariathasan co-founded a compliance AI startup and conducted machine learning research at a Harvard-HKU joint laboratory on computer vision applications in cancer detection. He holds a master's degree in biomedical engineering from Imperial College London and previously pursued doctoral studies in AI for health at Oxford.
AP
Ayush PatelCo-FounderAyush Patel is a computer scientist with an MEng from Imperial College London and two internships at Apple, where he worked on QA automation systems. He is co-founder of Osseus.
Investors · 2
Related companies · 5
LaminLamin provides a lineage-native lakehouse platform for biological R&D that enables scientists to query, trace, and validate complex biological datasets across academia, biotech, and pharma. The platform integrates data versioning and cataloging capabilities to close the feedback loop between experimental results and machine learning models.
FrekilFrekil automates real-world evidence generation for pharmaceutical and healthcare research, using AI agents to build patient cohorts, design studies, and generate statistical analyses from existing clinical data. The platform enables epidemiological workflows across drug safety monitoring, comparative effectiveness, label expansion, and trial feasibility assessments.
NumenNumen develops at-home cancer diagnostics and health data collection infrastructure using machine learning models to enable earlier intervention and improve patient outcomes.
MiracleMiracle unifies data from multiple clinical trial platforms to provide automated insights for healthcare professionals in biopharma. The company aims to accelerate clinical trial execution and help bring new therapeutics to market more efficiently.
DatalandDataland builds AI agents that handle complex, end-to-end business workflows for enterprises in healthcare, energy, logistics, and other sectors. The company embeds engineers with customers to design, build, and maintain bespoke agents that integrate with existing tools and take full ownership of outcomes rather than requiring customers to complete the implementation.
Companies working in the same space as Osseus.
Legal entities · 1
corporate structureOsseus, Inc.
Frequently asked questions
- What does Osseus do?
- Osseus builds a permissioned research brain that connects tools and data across R&D teams to surface past experiments, expert knowledge, and next actions. The platform serves technical and research teams in biotech, manufacturing, and similar knowledge-intensive industries by maintaining continuous memory of how work evolved and preventing repeated efforts.
- Who founded Osseus?
- Osseus was founded by Anish Mariathasan, Ayush Patel in 2026.
- Who are Osseus's investors?
- Osseus's investors include Vela Partners, Y Combinator.